Temporal trends and regional differences of initial oral antiarrhythmic drug options in patients with new-onset atrial fibrillation: a report from the GLORIA-AF registry

Back

ESC Premium Access

Temporal trends and regional differences of initial oral antiarrhythmic drug options in patients with new-onset atrial fibrillation: a report from the GLORIA-AF registry

Session: Novel and old treatments, evidence in large populations

Topic: Antiarrhythmic Pharmacotherapy

Speaker: Mr B. Huang (Chongqing, CN)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Mr Bi Huang

The First Affiliated Hospital of Chongqing Medical University, Chongqing (China)

0 follower

7 more presentations in this session

Ezetimibe use and mortality after myocardial infarction: a nationwide cohort study

Speaker: Doctor V. Kyto (Turku, FI)

Lipid-lowering therapy with Inclisiran in the real-world setting: initial data from a national health care service

Speaker: Associate Professor B. Zafrir (Haifa, IL)

Moderate-intensity statin combined with ezetimibe versus high-intensity statin monotherapy for secondary cardiovascular risk reduction: a systematic review and meta-analysis

Speaker: Mr M. Kritya (Pune, IN)

Efficacy and safety of intravenous iron therapy in heart failure patients with iron deficiency: a systematic review and meta-analysis of randomized controlled trials

Speaker: Doctor M. Abouzid (Poznan, PL)

Prognostic implications of guideline-directed medical therapy in functional mitral regurgitation: a meta-analysis

Speaker: Doctor V. Anastasiou (Thessaloniki, GR)

Access the full session

Novel and old treatments, evidence in large populations

Speakers: Mr B. Huang, Doctor V. Kyto, Associate Professor B. Zafrir, Mr M. Kritya, Doctor M. Abouzid...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources